Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.67+0.12 (+4.71%)
Close on Nov 17, 2026Market cap $92.82MP/E –Yield –
Anixa Biosciences cash
Cash and short-term investments held at the end of each period.
Anixa Biosciences's cash was $13.86M at Jul 31, 2026. For fiscal 2025 it was $15.17M, down 23.8% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $35.73M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $15.17M | -23.8% |
| FY2024 | Oct 31, 2024 | $19.92M | -16.4% |
| FY2023 | Oct 31, 2023 | $23.84M | -19.7% |
| FY2022 | Oct 31, 2022 | $29.69M | -16.9% |
| FY2021 | Oct 31, 2021 | $35.73M | +294.5% |
| FY2020 | Oct 31, 2020 | $9.06M | +55.0% |
| FY2019 | Oct 31, 2019 | $5.84M | +15.5% |
| FY2018 | Oct 31, 2018 | $5.06M | -26.1% |
| FY2017 | Oct 31, 2017 | $6.84M | +111.2% |
| FY2016 | Oct 31, 2016 | $3.24M | -52.2% |
| FY2015 | Oct 31, 2015 | $6.77M | +15.5% |
| FY2014 | Oct 31, 2014 | $5.86M | +552.7% |
| FY2013 | Oct 31, 2013 | $898.00K | +6.9% |
| FY2012 | Oct 31, 2012 | $840.00K | -72.2% |
| FY2011 | Oct 31, 2011 | $3.02M | +176.3% |
| FY2010 | Oct 31, 2010 | $1.09M | -24.6% |
| FY2009 | Oct 31, 2009 | $1.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $13.86M | -13.5% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $13.69M | -12.3% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $14.20M | -17.7% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $15.17M | -23.8% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $16.03M | -22.7% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $15.60M | -32.9% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $17.26M | -27.5% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $19.92M | -16.4% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $20.75M | -18.8% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $23.24M | -13.9% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $23.80M | -14.1% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $23.84M | -19.7% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $25.53M | -19.4% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $26.98M | -16.3% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $27.70M | -19.8% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $29.69M | -16.9% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $31.66M | -13.5% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $32.23M | -15.4% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $34.53M | +146.9% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $35.73M | +294.5% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $36.62M | +303.9% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $38.10M | +591.7% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $13.98M | +145.7% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $9.06M | +55.0% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $9.07M | +39.6% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $5.51M | -16.2% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $5.69M | -3.6% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $5.84M | +15.5% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $6.50M | +21.6% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $6.57M | +21.2% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $5.90M | +7.4% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $5.06M | -26.1% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $5.34M | -12.2% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $5.42M | +5.8% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $5.50M | +174.8% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $6.84M | +111.2% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $6.09M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $5.13M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $2.00M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $3.24M | – |
See a number that looks wrong?